chapter  18
12 Pages

Drug-Drug Interactions: Marketing Perspectives

The number of drugs available to treat patient illness is steadily increasing as drug development benefits from advances in molecular biology and from increasing automation of drug screening through the use of robotics and combinatorial chemistry. This ever-expanding pharmaceutical arsenal is available to physicians to treat a large number of diseases (both human and veterinary). As the mean age of industrialized nations increases, in part due to advances in medical care, the need to treat multiple disease processes simultaneously increases the probability that large numbers of people will receive concomitant therapy with multiple drugs. Consequently, there is an increased risk of adverse drug-drug interactions as more drugs are used to treat a variety of conditions in the same patient.